Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mersana Therapeutics buy Citigroup Inc.

Mersana Therapeutics
Start price
€1.27
17:00 / 50%
Target price
€4.48
27.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.08.25. The prediction end date can be changed by Citigroup_Inc_ at any time.
Performance without dividends (%)
Name 1w
Mersana Therapeutics -
iShares Core DAX® 1.056%
iShares Nasdaq 100 -1.886%
iShares Nikkei 225® 2.553%
iShares S&P 500 -0.434%

Comments by Citigroup_Inc_ for this prediction

In the thread Mersana Therapeutics diskutieren
Prediction Buy
Perf. (%) -
Target price 4.477
Change
Ends at 27.08.25

Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Citigroup Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat

Citigroup Inc. 
0
Report Share
17:00

Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.71
04.12.23
€4.61
04.12.24
-16.99%
22.08.24

Citigroup Inc. 
04.12.23 50%